文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

坦桑尼亚接受乳房切除术的乳腺癌患者手术切缘分析。

Analysis of surgical margins in breast cancer patients undergoing mastectomy in Tanzania.

作者信息

Kivuyo Nashivai, Amin Abdulrahaman, Gega Zephania, Akoko Larry

机构信息

Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Department of Surgery, Muhimbili National Hospital, Dar es Salaam, Tanzania.

出版信息

BMC Surg. 2025 Aug 9;25(1):358. doi: 10.1186/s12893-025-03118-x.


DOI:10.1186/s12893-025-03118-x
PMID:40783732
Abstract

BACKGROUND: The quality and completeness of surgery remains critical for optimal oncological outcomes in breast cancer. A key indicator of surgical completeness is the resection margin status, which should ideally be negative, indicated by no ink on invasive tumor. However, such data is rarely reported from sub-Saharan Africa. This study aims to describe the clinical characteristics of women with non-metastatic breast cancer who underwent a mastectomy, and identify the factors influencing the resection margin status at a cancer hospital in Tanzania. METHODOLOGY: This was a retrospective cohort study analyzing clinical and pathological data of female patients, with a histologically confirmed breast cancer at stage I-III, who underwent a mastectomy at Muhimbili National Hospital in Tanzania. Data were extracted from histopathology reports and clinical records, focusing on margin status and associated variables including age, tumor size (T-status), nodal involvement (N-status), histological subtype, grade, luminal subtype, laterality, and receipt of neo-adjuvant therapy. The primary outcome was margin status post mastectomy. Descriptive statistics were used to summarize patient characteristics, and chi-square tests were applied to assess associations between variables and margin status. Statistical significance was set at p < 0.05. RESULTS: Out of the 1,020 patients analyzed, margin status was documented for 976 cases. Among these, 801 patients (82.1%) had negative margins, while 175 (17.9%) had positive or close margins; of the latter, 88.6% were positive and 11.4% close. Most patients with margin involvement (88%) had only a single margin affected. The deep margin was most frequently involved in 87% of patients with involved margins, followed by the superior margin in 57%. Margin involvement was significantly higher among younger patients, particularly those under 30 years of age (p < 0.001), and was also strongly associated with advanced T-status (p < 0.001), especially T4 tumors, where 31.7% had involved margins. No significant associations were found with histological subtype, luminal classification, laterality, receipt of neoadjuvant therapy. CONCLUSION: This study revealed a high rate of margin positivity following mastectomy, largely driven by advanced tumor stage and young age at presentation. To improve surgical outcomes in low-resource settings, we recommend interventions to improve earlier diagnosis and expanded use of neoadjuvant therapy for patients with locally advanced disease.

摘要

背景:手术的质量和完整性对于乳腺癌获得最佳肿瘤学结局仍然至关重要。手术完整性的一个关键指标是切缘状态,理想情况下应为阴性,即浸润性肿瘤上无墨水标记。然而,撒哈拉以南非洲地区很少报告此类数据。本研究旨在描述接受乳房切除术的非转移性乳腺癌女性的临床特征,并确定坦桑尼亚一家癌症医院影响切缘状态的因素。 方法:这是一项回顾性队列研究,分析了在坦桑尼亚穆希姆比利国家医院接受乳房切除术、组织学确诊为I - III期乳腺癌的女性患者的临床和病理数据。数据从组织病理学报告和临床记录中提取,重点关注切缘状态及相关变量,包括年龄、肿瘤大小(T分期)、淋巴结受累情况(N分期)、组织学亚型、分级、腔面亚型、患侧以及新辅助治疗的接受情况。主要结局是乳房切除术后的切缘状态。采用描述性统计来总结患者特征,并应用卡方检验评估变量与切缘状态之间的关联。统计学显著性设定为p < 0.05。 结果:在分析的1020例患者中,976例记录了切缘状态。其中,801例患者(82.1%)切缘阴性,而175例(17.9%)切缘阳性或接近阳性;后者中,88.6%为阳性,11.4%为接近阳性。大多数切缘受累患者(88%)仅一个切缘受影响。在切缘受累的患者中,87%的患者最常受累的是深部切缘,其次是上切缘,占57%。年轻患者,尤其是30岁以下患者,切缘受累显著更高(p < 0.001),并且也与晚期T分期密切相关(p < 0.001),特别是T4肿瘤,其中31.7%的患者切缘受累。未发现与组织学亚型、腔面分类、患侧、新辅助治疗的接受情况有显著关联。 结论:本研究显示乳房切除术后切缘阳性率较高,主要由肿瘤晚期和就诊时年龄较轻所致。为改善资源匮乏地区的手术结局,我们建议采取干预措施以改善早期诊断,并扩大对局部晚期疾病患者使用新辅助治疗。

相似文献

[1]
Analysis of surgical margins in breast cancer patients undergoing mastectomy in Tanzania.

BMC Surg. 2025-8-9

[2]
Prophylactic mastectomy for the prevention of breast cancer.

Cochrane Database Syst Rev. 2004-10-18

[3]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[4]
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

Cochrane Database Syst Rev. 2015-4-7

[5]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

[6]
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.

Cochrane Database Syst Rev. 2022-9-26

[7]
Different types of implants for reconstructive breast surgery.

Cochrane Database Syst Rev. 2016-5-16

[8]
Oncological Outcomes of Intersphincteric Resection Versus Abdominoperineal Resection for ypT3 Low Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Multicenter Retrospective Analysis.

Dis Colon Rectum. 2025-8-1

[9]
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Health Technol Assess. 2007-11

[10]
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.

Clin Orthop Relat Res. 2023-11-1

本文引用的文献

[1]
Measuring the WHO Global Breast Cancer Initiative Pillars' key performance indicators in Sub-Saharan Africa: experience in the African Breast Cancer-Disparities in Outcomes hospital-based cohort study.

EClinicalMedicine. 2025-2-13

[2]
Identifying Factors Predicting Margin Status After Mastectomy.

Ann Surg Oncol. 2024-12

[3]
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2024

[4]
Localised breast cancer: neoadjuvant chemotherapy impact evaluation on the pathological complete response (PCR) in a lower middle-income country.

Ecancermedicalscience. 2023-12-15

[5]
Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer.

Breast Cancer Res Treat. 2024-2

[6]
Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives.

Breast Cancer (Dove Med Press). 2023-10-20

[7]
Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions.

Int J Equity Health. 2023-9-11

[8]
Treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African Breast Cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study.

Lancet Oncol. 2022-6

[9]
Tumor margins that lead to reoperation in breast cancer: A retrospective register study of 4,489 patients.

J Surg Oncol. 2022-3

[10]
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

Ann Oncol. 2021-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索